Length-independent telomere damage drives post-mitotic cardiomyocyte senescence
- PMID: 30737259
- PMCID: PMC6396144
- DOI: 10.15252/embj.2018100492
Length-independent telomere damage drives post-mitotic cardiomyocyte senescence
Abstract
Ageing is the biggest risk factor for cardiovascular disease. Cellular senescence, a process driven in part by telomere shortening, has been implicated in age-related tissue dysfunction. Here, we address the question of how senescence is induced in rarely dividing/post-mitotic cardiomyocytes and investigate whether clearance of senescent cells attenuates age-related cardiac dysfunction. During ageing, human and murine cardiomyocytes acquire a senescent-like phenotype characterised by persistent DNA damage at telomere regions that can be driven by mitochondrial dysfunction and crucially can occur independently of cell division and telomere length. Length-independent telomere damage in cardiomyocytes activates the classical senescence-inducing pathways, p21CIP and p16INK4a, and results in a non-canonical senescence-associated secretory phenotype, which is pro-fibrotic and pro-hypertrophic. Pharmacological or genetic clearance of senescent cells in mice alleviates detrimental features of cardiac ageing, including myocardial hypertrophy and fibrosis. Our data describe a mechanism by which senescence can occur and contribute to age-related myocardial dysfunction and in the wider setting to ageing in post-mitotic tissues.
Keywords: ageing; cardiomyocytes; senescence; senolytics; telomeres.
© 2019 The Authors. Published under the terms of the CC BY 4.0 license.
Conflict of interest statement
Patents on INK‐ATTAC mice are held by Mayo Clinic and licensed to Unity Biotechnology. J.L.K. and T.T. may gain financially from these patents and licences. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest policies. The remaining authors declare no competing financial interests.
Figures
Comment in
-
Length doesn't matter-telomere damage triggers cellular senescence in the ageing heart.EMBO J. 2019 Mar 1;38(5):e101571. doi: 10.15252/embj.2019101571. Epub 2019 Feb 15. EMBO J. 2019. PMID: 30770342 Free PMC article.
Similar articles
-
Selective Cardiomyocyte Oxidative Stress Leads to Bystander Senescence of Cardiac Stromal Cells.Int J Mol Sci. 2021 Feb 24;22(5):2245. doi: 10.3390/ijms22052245. Int J Mol Sci. 2021. PMID: 33668142 Free PMC article.
-
Telomeres and telomerase in risk assessment of cardiovascular diseases.Exp Cell Res. 2020 Dec 15;397(2):112361. doi: 10.1016/j.yexcr.2020.112361. Epub 2020 Nov 7. Exp Cell Res. 2020. PMID: 33171154 Review.
-
Molecular Aspects of Senescence and Organismal Ageing-DNA Damage Response, Telomeres, Inflammation and Chromatin.Int J Mol Sci. 2021 Jan 8;22(2):590. doi: 10.3390/ijms22020590. Int J Mol Sci. 2021. PMID: 33435578 Free PMC article. Review.
-
Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response.Aging Cell. 2012 Dec;11(6):996-1004. doi: 10.1111/j.1474-9726.2012.00870.x. Epub 2012 Sep 12. Aging Cell. 2012. PMID: 22882466 Free PMC article.
-
The roles of senescence and telomere shortening in cardiovascular disease.Nat Rev Cardiol. 2013 May;10(5):274-83. doi: 10.1038/nrcardio.2013.30. Epub 2013 Mar 12. Nat Rev Cardiol. 2013. PMID: 23478256 Review.
Cited by
-
P16INK4A-More Than a Senescence Marker.Life (Basel). 2022 Aug 28;12(9):1332. doi: 10.3390/life12091332. Life (Basel). 2022. PMID: 36143369 Free PMC article. Review.
-
Ameliorative effects of mesenchymal stromal cells on senescence associated phenotypes in naturally aged rats.J Transl Med. 2024 Aug 5;22(1):722. doi: 10.1186/s12967-024-05486-z. J Transl Med. 2024. PMID: 39103873 Free PMC article.
-
Therapeutic Potential of Senolytics in Cardiovascular Disease.Cardiovasc Drugs Ther. 2022 Feb;36(1):187-196. doi: 10.1007/s10557-020-07075-w. Epub 2020 Sep 26. Cardiovasc Drugs Ther. 2022. PMID: 32979174 Free PMC article. Review.
-
Heart Failure with Preserved Ejection Fraction: The Pathophysiological Mechanisms behind the Clinical Phenotypes and the Therapeutic Approach.Int J Mol Sci. 2024 Jan 8;25(2):794. doi: 10.3390/ijms25020794. Int J Mol Sci. 2024. PMID: 38255869 Free PMC article. Review.
-
Telomeres as hotspots for innate immunity and inflammation.DNA Repair (Amst). 2024 Jan;133:103591. doi: 10.1016/j.dnarep.2023.103591. Epub 2023 Nov 5. DNA Repair (Amst). 2024. PMID: 37951043 Free PMC article. Review.
References
-
- Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, Athineos D, Kang T‐W, Lasitschka F, Andrulis M, Pascual G, Morris KJ, Khan S, Jin H, Dharmalingam G, Snijders AP, Carroll T, Capper D, Pritchard C, Inman GJ et al (2013) A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 15: 978–990 - PMC - PubMed
-
- d'Adda di Fagagna F, Reaper PM, Clay‐Farrace L, Fiegler H, Carr P, von Zglinicki T, Saretzki G, Carter NP, Jackson SP (2003) A DNA damage checkpoint response in telomere‐initiated senescence. Nature 426: 194–198 - PubMed
-
- Anderson R, Richardson GD, Passos JF (2018) Mechanisms driving the ageing heart. Exp Gerontol 109: 5–15 - PubMed
-
- Bae NS, Baumann P (2007) A RAP1/TRF2 complex inhibits nonhomologous end‐joining at human telomeric DNA ends. Mol Cell 26: 323–334 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- PG/14/86/31177/BHF_/British Heart Foundation/United Kingdom
- R01 HL141819/HL/NHLBI NIH HHS/United States
- R37 AG013925/AG/NIA NIH HHS/United States
- MR/L016354/1/MRC_/Medical Research Council/United Kingdom
- P01 AG031862/AG/NIA NIH HHS/United States
- PG/15/85/31744/BHF_/British Heart Foundation/United Kingdom
- R01 AG013925/AG/NIA NIH HHS/United States
- PG/19/15/34269/BHF_/British Heart Foundation/United Kingdom
- G0700718/MRC_/Medical Research Council/United Kingdom
- BB/H022384/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases